pharma

Oregon Legislators Detail Their Health Agenda for Upcoming Session

Five Oregon lawmakers, Sen. Laurie Monnes Anderson and Reps. Mitch Greenlick, Cedric Hayden, Rob Nosse and Alissa Keny-Guyer, discussed bills addressing everything from mental health to drug costs to oral health education that they plan to submit in the session which starts in January.

A six-month legislative session kicks off in January, and policymakers plan to introduce robust health care legislation.

Oregon Aims to Eliminate Hepatitis C Infections

The state has the highest mortality rate in the country but a move by the Oregon Health Authority to expand expensive treatment could wipe out the virus, if medical modeling is correct.

The Oregon Health Authority is moving to expand treatment for hepatitis C to everyone on the Oregon Health Plan who’s infected.

Democrats Taking Key Leadership Jobs Have Pocketed Millions From Pharma

Three lawmakers who will lead the U.S. House next year are among the biggest recipients of campaign contributions from the pharmaceutical industry.

Three of the lawmakers who will lead the House next year as Congress focuses on skyrocketing drug costs are among the biggest recipients of campaign contributions from the pharmaceutical industry, a new KHN analysis shows.

Heart Drug Spotlights Troubling Trends In Drug Marketing

A company is marketing a drug intended as a preventive for people at risk for heart disease with stunning statistics but has not yet released details of its study.

At the end of September, Amarin Corp. teased some early findings for Vascepa, its preventive medicine for people at risk of heart disease. The claim was astounding: a 25 percent relative risk reduction for deaths related to heart attacks, strokes and other conditions.

Congress Bans Pharmacist ‘Gag Orders’ On Drug Prices

Pharmacists have been prevented from telling consumers when the cash price for a drug is lower than the cost through their insurer. But critics say this will not affect the causes of high drug prices.

For years, most pharmacists couldn’t give customers even a clue about an easy way to save money on prescription drugs. But the restraints are coming off.

Subscribe to pharma